Item 5.07. Submission of Matters to a Vote of Security Holders.

On May 31, 2023, Pharma-Bio Serv, Inc. (the "Company") held its 2023 Annual Meeting of Stockholders (the "Annual Meeting"). Below is a summary of the proposals and corresponding votes.

Irving Wiesen was elected as a Class I director by a plurality of the shares present in person or represented by proxy at the Annual Meeting and entitled to vote. Mr. Wiesen shall serve as a Class I director until the 2026 Annual Meeting of Stockholders or until his successor is duly elected and qualified. The votes for this proposal were as follows:





   Nominee    Votes For Votes Withheld
Irving Wiesen 7,477,036   11,696,947

There were 515,852 broker non-votes on this proposal.

The ratification of the selection of Crowe PR PSC as the Company's independent certified public accountants for the fiscal year ending October 31, 2023 received the following votes:





Votes For  Votes Against  Abstain
14,344,226   1,492,688   3,852,921

There were no broker non-votes on this proposal.






2

© Edgar Online, source Glimpses